GWI
NWBO

Grace & White Inc’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Grace & White Inc’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,705
Closed -$9.19K – 150
2023
Q1 		$9.19K Hold
14,705
– – ﹤0.01% 137
2022
Q4 		$11.5K Hold
14,705
– – ﹤0.01% 129
2022
Q3 		$10K Sell
14,705
-10,600
-42% -$7.21K ﹤0.01% 129
2022
Q2 		$16K Hold
25,305
– – ﹤0.01% 129
2022
Q1 		$18K Hold
25,305
– – ﹤0.01% 130
2021
Q4 		$18K Hold
25,305
– – ﹤0.01% 131
2021
Q3 		$32K Hold
25,305
– – 0.01% 131
2021
Q2 		$37K Hold
25,305
– – 0.01% 128
2021
Q1 		$38K Buy
25,305
+14,705
+139% +$22.1K 0.01% 126
2020
Q4 		$16K Buy
+10,600
New +$16K ﹤0.01% 126

Other funds holding NWBO

SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LDB
Lee, Danner & Bass Nashville, Tennessee $1.73B AUM 36.69% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $549M AUM 29.35% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return
BC
Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return

Grace & White Inc's NWBO Position: Q2 2023 in Review

Grace & White Inc sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q2 2023, closing a stake of 14,705 shares — an estimated $9.19K sold.

Grace & White Inc first reported a position in NWBO in Q4 2020 and held it in 10 quarters. The position peaked at $38K in Q1 2021. 11 funds tracked by Wall St. Rank hold NWBO as of Q2 2023.

  • Grace & White Inc reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q2 2023 after selling out during the quarter.
  • Grace & White Inc sold 14,705 Northwest Biotherapeutics, Inc. Common stock shares in Q2 2023, an estimated $9.19K.
  • Grace & White Inc first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q4 2020 and held it in 10 quarters.
  • Grace & White Inc's Northwest Biotherapeutics, Inc. Common stock position peaked at $38K in Q1 2021.
  • 11 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q2 2023.

Based on Grace & White Inc's 13F filing for Q2 2023, filed 26 Jul 2023.